Lysteda Dosage
Generic name: TRANEXAMIC ACID 650mg
Dosage form: tablet
Drug class: Miscellaneous coagulation modifiers
Medically reviewed by Drugs.com. Last updated on Nov 22, 2023.
Recommended Testing Prior to LYSTEDA Administration
Prior to prescribing LYSTEDA, exclude endometrial pathology that can be associated with heavy menstrual bleeding.
Recommended Dosage
The recommended dosage of LYSTEDA for patients with normal renal function is 1300 mg orally three times daily (3900 mg/day) for a maximum of 5 days during monthly menstruation. LYSTEDA may be administered with or without food. Swallow tablets whole; do not chew or break apart.
Dosage Recommendations in Patients with Renal Impairment
The recommended dosage (for a maximum of 5 days during monthly menstruation) in patients with renal impairment with serum creatinine concentration higher than 1.4 mg/dL is described in Table 1.
| Serum Creatinine (mg/dL) |
Recommended Dosage (maximum of 5 days during menstruation) |
Total Daily Dose |
|---|---|---|
| Above 1.4 and ≤ 2.8 | 1300 mg two times a day | 2600 mg |
| Above 2.8 and ≤ 5.7 | 1300 mg once a day | 1300 mg |
| Above 5.7 | 650 mg once a day | 650 mg |
More about Lysteda (tranexamic acid)
- Check interactions
- Compare alternatives
- Reviews (70)
- Drug images
- Latest FDA alerts (1)
- Side effects
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
